The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men.

Abstract:

AIMS/HYPOTHESIS:The relationship of androgens to the metabolic syndrome has not been resolved. The polymorphic number of CAG repeats within the androgen receptor gene is inversely associated with the transcriptional activity of target genes. This polymorphism might thus influence testosterone effects on body fat content and serum concentrations of leptin and insulin. The direct and indirect role of androgens within the metabolic syndrome should become clearer if this genetically determined effector is taken into account. METHODS:The hypothesis was investigated in a cross-sectional study involving 106 healthy 20-50 year old males. RESULTS:Multiple regression models showed a positive independent correlation of the CAG repeat number with body fat content, leptin and insulin (partial r=0.39, 0.36 and 0.28, p<0.001, p<0.001 and p=0.006, respectively). Factor analysis yielded a five-dimensional model: two dimensions were influenced by the androgen receptor polymorphism, namely "body composition" which consisted of leptin, body fat mass, insulin, the number of CAG repeats (positive loadings) and physical activity (negative loading), and "lipid profile" which comprised low density lipoprotein cholesterol, cigarette smoking, triglycerides (positive loadings) as well as high density lipoprotein cholesterol and number of CAG repeats (negative loadings). CONCLUSIONS/INTERPRETATION:A low number of CAG repeats were independently associated with protective parameters (low body fat mass and plasma insulin) as well as with adverse parameters (low high density lipoprotein cholesterol concentrations). This suggests that the pivotal role of this polymorphism in modulating androgen effects on cardiovascular risk factors is of a complex nature and implies that its clinical impact, similar to that of androgens, is dependent on exogenous cofactors.

journal_name

Diabetologia

journal_title

Diabetologia

authors

Zitzmann M,Gromoll J,von Eckardstein A,Nieschlag E

doi

10.1007/s00125-002-0980-9

subject

Has Abstract

pub_date

2003-01-01 00:00:00

pages

31-9

issue

1

eissn

0012-186X

issn

1432-0428

journal_volume

46

pub_type

杂志文章
  • Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions.

    abstract::This study aimed at verifying whether thiamine, a co-enzyme which decreases intracellular glycolysis metabolites by allowing pyruvate and glyceraldheyde 3-phosphate to enter the Krebs cycle and the pentose-phosphate shunt, respectively, corrects delayed replication caused by high glucose concentrations in cultured hum...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s001250050568

    authors: La Selva M,Beltramo E,Pagnozzi F,Bena E,Molinatti PA,Molinatti GM,Porta M

    更新日期:1996-11-01 00:00:00

  • Elevated GLUT 1 level in crude muscle membranes from diabetic Zucker rats despite a normal GLUT 1 level in perineurial sheaths.

    abstract::Recently, we demonstrated that approximately 60% of GLUT 1 in a crude membrane fraction of rat skeletal muscle originates from perineurial sheaths. To study the in vivo regulation of GLUT 1 expression in different tissues in muscles, we measured the level of GLUT 1 in crude muscle membranes and in perineurial sheaths ...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s001250050130

    authors: Handberg A,Kayser L,Høyer PE,Micheelsen J,Vinten J

    更新日期:1994-05-01 00:00:00

  • The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus.

    abstract:AIM/HYPOTHESIS:The renin-angiotensin-aldosterone system is important in diabetic nephropathy, with the angiotensin-converting-enzyme DD-genotype being a renal risk factor. The D-allele is associated with higher ACE concentrations, but functional consequences in diabetes mellitus are not known. To analyse these conseque...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-003-1149-x

    authors: Luik PT,Hoogenberg K,Kerstens MN,Beusekamp BJ,De Jong PE,Dullaart RP,Navis GJ

    更新日期:2003-08-01 00:00:00

  • Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.

    abstract:AIMS/HYPOTHESIS:High levels of inflammation locally in the graft during the initial days after transplantation can cause primary non-function (PNF) of grafted xenogeneic islets in NOD mice. The aim of this study was to explore in a model of spontaneous diabetes, the NOD mouse, the potential of anti-inflammatory agents ...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-003-1154-0

    authors: Gysemans C,Stoffels K,Giulietti A,Overbergh L,Waer M,Lannoo M,Feige U,Mathieu C

    更新日期:2003-08-01 00:00:00

  • Major lower limb amputation in diabetic patients: development during 1982 to 1993.

    abstract::This study analyses 2848 primary major lower limb amputations in diabetic individuals during the period 1982-1993. The male:female sex ratio (mean 1.18) increased, while the mean age at the primary amputation was constant (70.96 years) during the period. The incidence uniformly decreased for both men and women by 0.96...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s001250050622

    authors: Ebskov B,Ebskov L

    更新日期:1996-12-01 00:00:00

  • The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men.

    abstract:AIMS/HYPOTHESIS:Glucagon-like peptide-1 (GLP-1), a polypeptide hormone secreted by the l-cells in the gastrointestinal tract, has shown promising effects as a new treatment modality for patients with Type II (non-insulin-dependent) diabetes mellitus. However, the pharmacokinetic profile of native GLP-1 with a rapid eli...

    journal_title:Diabetologia

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s00125-001-0719-z

    authors: Agersø H,Jensen LB,Elbrønd B,Rolan P,Zdravkovic M

    更新日期:2002-02-01 00:00:00

  • Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.

    abstract::Amylin is a 37-amino acid pancreatic polypeptide, probably involved in the pathophysiology of Type 2 (non-insulin-dependent) diabetes mellitus. We have determined amylin in human plasma by extraction-based radioimmunoassay (Sep-Pak C18). Of 23 healthy control subjects plasma amylin was determined as 11.9 +/- 3.5 ng/l....

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00404025

    authors: Hartter E,Svoboda T,Ludvik B,Schuller M,Lell B,Kuenburg E,Brunnbauer M,Woloszczuk W,Prager R

    更新日期:1991-01-01 00:00:00

  • Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line.

    abstract:AIMS/HYPOTHESIS:To investigate the pathways by which cyclic AMP (cAMP) stimulates glucagon-like peptide-1 (GLP-1) secretion, using the GLUTag enteroendocrine cell line. MATERIALS AND METHODS:GLP-1 release from GLUTag cells was measured in response to agents that increase cAMP, and single cells were studied by fluoresc...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-007-0750-9

    authors: Simpson AK,Ward PS,Wong KY,Collord GJ,Habib AM,Reimann F,Gribble FM

    更新日期:2007-10-01 00:00:00

  • Dihydroergotamine, but not naloxone, counteracts lithium as an inhibitor of glucose-induced insulin release in isolated rat islets in vitro.

    abstract::Lithium exerts an inhibitory effect on glucose-induced insulin release. Lithium (5 mmol/l) added 30 min prior to glucose stimulation or together with glucose (16.7 mmol/l) failed to affect first phase, but reduced second phase glucose-induced insulin release by 35%. Similar results were obtained when islets isolated f...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00274225

    authors: Fontela T,Garcia Hermida O,Gómez-Acebo J

    更新日期:1987-03-01 00:00:00

  • The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitus.

    abstract:AIMS/HYPOTHESIS:Growth hormone hypersecretion in Type 1 diabetes could exacerbate insulin resistance and contribute to declining glycaemic control. Our aim was to determine the effects of specific growth hormone blockade on insulin sensitivity and lipolysis in young adults with Type 1 diabetes. METHODS:We studied the ...

    journal_title:Diabetologia

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s00125-003-1175-8

    authors: Williams RM,Amin R,Shojaee-Moradie F,Umpleby AM,Acerini CL,Dunger DB

    更新日期:2003-09-01 00:00:00

  • Insulin dependent diabetes: a comparison of families with single and multiple affected siblings.

    abstract::Families (n = 14) with more than 1 sibling with insulin dependent diabetes were matched with families of similar size and age distribution containing only 1 affected child. The distribution of HLA haplotypes, age of onset of disease, and seasonal onset of disease were compared in the two groups. The data are not consi...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00421852

    authors: Jaworski MA,Colle E,Guttmann RD,Belmonte MM,Taylor B,Crepeau MP,Wilkins J,Poirier R

    更新日期:1980-08-01 00:00:00

  • Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice.

    abstract:AIMS/HYPOTHESIS:Type 1 diabetes increases the risk of peripheral ischaemia and impairs recovery once ischaemia occurs, probably because the healing process is hampered by diabetes-induced endothelial dysfunction. In normoglycaemic mice subjected to limb ischaemia, blockade of nerve growth factor (NGF) compromises repar...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-004-1424-5

    authors: Salis MB,Graiani G,Desortes E,Caldwell RB,Madeddu P,Emanueli C

    更新日期:2004-06-01 00:00:00

  • Infusion of pH 2.0 D-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycaemia.

    abstract::We compared the effects of infusing a chemically defined chiro-inositol glycan putative insulin mediator with an equivalent dose of insulin in low-dose (45 mg/kg) streptozotocin diabetic rats. Insulin decreased plasma glucose levels from 17.32 +/- 0.17 to 3.96 +/- 0.064 mmol/l (p < 0.0002) in 120 min, a decrease of 77...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00418546

    authors: Fonteles MC,Huang LC,Larner J

    更新日期:1996-06-01 00:00:00

  • cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis.

    abstract:AIMS/HYPOTHESIS:Fenofibrate is a drug used to treat hyperlipidaemia that works by inhibiting hepatic triacylglycerol synthesis. Sterol regulatory element binding protein-1c (SREBP-1c) is a major regulator of the expression of genes involved in hepatic triacylglycerol synthesis. In addition, endoplasmic reticulum (ER)-b...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-012-2771-2

    authors: Min AK,Jeong JY,Go Y,Choi YK,Kim YD,Lee IK,Park KG

    更新日期:2013-02-01 00:00:00

  • Thermoregulatory responses to hyperinsulinaemic hypoglycaemia and euglycaemia in IDDM.

    abstract::In healthy subjects hypoglycaemia causes a fall in body temperature through increased sweating and limb blood flow, and despite increased metabolic heat production. We studied thermoregulatory responses to hyperinsulinaemic (100 mU.m-2.min-1) (a) hypoglycaemia (2.5 mmol/l) and (b) euglycaemia (4.5 mmol/l) in insulin-d...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00417693

    authors: Maggs DG,Macdonald IA,Tattersall RB

    更新日期:1994-07-01 00:00:00

  • PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.

    abstract:AIMS/HYPOTHESIS:The first clinical manifestation of diabetes is polyuria. The prostaglandin E2 (PGE2) receptor EP3 antagonises arginine vasopressin (AVP)-mediated water reabsorption and its expression is increased in the diabetic kidney. The purpose of this work was to study the contribution of EP3 to diabetic polyuria...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-016-3916-5

    authors: Hassouneh R,Nasrallah R,Zimpelmann J,Gutsol A,Eckert D,Ghossein J,Burns KD,Hébert RL

    更新日期:2016-06-01 00:00:00

  • Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.

    abstract:AIMS/HYPOTHESIS:Genetic studies show coupling of genes affecting beta cell function to type 1 diabetes, but hitherto no studies on whether beta cell dysfunction could precede insulitis and clinical onset of type 1 diabetes are available. METHODS:We used 40-day-old BioBreeding (BB) DRLyp/Lyp rats (a model of spontaneou...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-017-4512-z

    authors: Medina A,Parween S,Ullsten S,Vishnu N,Siu YT,Quach M,Bennet H,Balhuizen A,Åkesson L,Wierup N,Carlsson PO,Ahlgren U,Lernmark Å,Fex M

    更新日期:2018-04-01 00:00:00

  • Pharmacokinetics of continuous subcutaneous insulin infusion.

    abstract::One of the reasons for the variability of blood glucose regulation in Type 1 (insulin-dependent) diabetic patients is the huge variation in subcutaneous absorption of intermediate-acting insulin. We have investigated the variation in insulin absorption during continuous subcutaneous insulin infusion in eight such pati...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00251817

    authors: Lauritzen T,Pramming S,Deckert T,Binder C

    更新日期:1983-05-01 00:00:00

  • Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.

    abstract:AIMS/HYPOTHESIS:Reactive oxygen species (ROS) contribute to diabetes-induced glomerular injury and endoplasmic reticulum (ER) stress-induced beta cell dysfunction, but the source of ROS has not been fully elucidated. Our aim was to determine whether p47(phox)-dependent activation of NADPH oxidase is responsible for hyp...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-012-2586-1

    authors: Liu GC,Fang F,Zhou J,Koulajian K,Yang S,Lam L,Reich HN,John R,Herzenberg AM,Giacca A,Oudit GY,Scholey JW

    更新日期:2012-09-01 00:00:00

  • Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes.

    abstract:AIMS/HYPOTHESIS:Results from animal models and some clinical work suggest a role for the central nervous system (CNS) in glucose regulation and type 2 diabetes pathogenesis by modulation of glucoregulatory hormones and the autonomic nervous system (ANS). The aim of this study was to characterise the neuroendocrine resp...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-020-05332-z

    authors: Lundqvist MH,Almby K,Wiklund U,Abrahamsson N,Kamble PG,Pereira MJ,Eriksson JW

    更新日期:2020-11-26 00:00:00

  • Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study.

    abstract:AIMS/HYPOTHESIS:Adiponectin is a circulating peptide derived from adipose tissue. It mediates its insulin-sensitising and anti-atherogenic effects on target tissues through two known receptors, adiponectin receptors 1 and 2 (ADIPOR1; ADIPOR2), which are encoded by the genes ADIPOR1 and ADIPOR2. Our aim was to study the...

    journal_title:Diabetologia

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s00125-006-0291-7

    authors: Siitonen N,Pulkkinen L,Mager U,Lindström J,Eriksson JG,Valle TT,Hämäläinen H,Ilanne-Parikka P,Keinänen-Kiukaanniemi S,Tuomilehto J,Laakso M,Uusitupa M

    更新日期:2006-08-01 00:00:00

  • Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL/6J mice.

    abstract:AIMS/HYPOTHESIS:In the current study, the effect of a highly specific peptide inhibitor of glycogen synthase kinase 3 (GSK3) (L803-mts) on glucose metabolism and BP was examined in a high-fat (HF) fed mouse model of diabetes. METHODS:C57/BL6J mice were placed on an HF diet for 3 months and treated with L803-mts for 20...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-006-0552-5

    authors: Rao R,Hao CM,Redha R,Wasserman DH,McGuinness OP,Breyer MD

    更新日期:2007-02-01 00:00:00

  • Vanadate treatment rapidly improves glucose transport and activates 6-phosphofructo-1-kinase in diabetic rat intestine.

    abstract::The effect of oral vanadate on intestinal sodium-dependent glucose transport and 6-phosphofructo-1-kinase (EC 2.7.1.11) activity was examined in male Sprague-Dawley rats following a 30-day period of non-treated streptozotocin-induced diabetes. Non-treated diabetic rats were hyperglycaemic and demonstrated increased in...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00410277

    authors: Madsen KL,Ariano D,Fedorak RN

    更新日期:1995-04-01 00:00:00

  • Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways.

    abstract::We have recently shown that leptin mimicks insulin effects on glucose transport and glycogen synthesis through a phosphatidylinositol-3 (PI) kinase dependent pathway in C2C12 myotubes. The aim of the present study was to identify the signalling path from the leptin receptor to the PI-3 kinase. We stimulated C2C12 myot...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s001250050832

    authors: Kellerer M,Koch M,Metzinger E,Mushack J,Capp E,Häring HU

    更新日期:1997-11-01 00:00:00

  • Prospective associations of circulating adipocyte fatty acid-binding protein levels with risks of renal outcomes and mortality in type 2 diabetes.

    abstract:AIMS/HYPOTHESIS:Elevated circulating adipocyte fatty acid-binding protein (AFABP) levels have been found to correlate with diabetic nephropathy staging in cross-sectional studies. However, it remains unclear whether these higher serum levels reflect a role of AFABP in the development of diabetic kidney disease (DKD), o...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-018-4742-8

    authors: Lee CH,Cheung CYY,Woo YC,Lui DTW,Yuen MMA,Fong CHY,Chow WS,Xu A,Lam KSL

    更新日期:2019-01-01 00:00:00

  • Pairing-up SOX to kick-start beta cell genesis.

    abstract::The transcription factor SOX9 is regarded as a crucial player in pancreas development, both maintaining progenitors and later being required for beta cell differentiation. However, very little is known about the possible involvement of other SOX family members in such processes. In this issue, the work of Xu et al (DO...

    journal_title:Diabetologia

    pub_type: 评论,杂志文章

    doi:10.1007/s00125-015-3539-2

    authors: Grapin-Botton A,Seymour PA,Gradwohl G

    更新日期:2015-05-01 00:00:00

  • HLA-DR 3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes.

    abstract::The presence of HLA-DR 3 was analysed in 745 patients with Type 1 (insulin-dependent) diabetes with age at diagnosis between 1-19 years. HLA-DR 3 and/or 4 was found in 678/745 (91%) of the patients. Presence of DR2 with neither DR 3 nor 4 was demonstrated in 15 patients. Patients with HLA-DR 3 without DR 4 presented w...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00454876

    authors: Ludvigsson J,Samuelsson U,Beauforts C,Deschamps I,Dorchy H,Drash A,Francois R,Herz G,New M,Schober E

    更新日期:1986-04-01 00:00:00

  • Leptin as an adjunct of insulin therapy in insulin-deficient diabetes.

    abstract:AIMS/HYPOTHESIS:The purpose of this study was to assess the therapeutic implication of leptin in insulin-deficient diabetes. METHODS:Insulin-deficient diabetes was induced by streptozotocin (STZ) in transgenic skinny mice overexpressing leptin. Plasma concentrations of glucose, insulin, and leptin were measured. The e...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-003-1193-6

    authors: Miyanaga F,Ogawa Y,Ebihara K,Hidaka S,Tanaka T,Hayashi S,Masuzaki H,Nakao K

    更新日期:2003-10-01 00:00:00

  • The HIV-1 protease inhibitor indinavir impairs insulin signalling in HepG2 hepatoma cells.

    abstract:AIMS/HYPOTHESIS:Patients treated with human immunodeficiency virus-1 protease inhibitors often develop impaired glucose tolerance or diabetes, most likely due to an induction of insulin resistance. We therefore investigated whether the protease inhibitor indinavir alters insulin signalling. METHODS:We incubated HepG2 ...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s001250051505

    authors: Schütt M,Meier M,Meyer M,Klein J,Aries SP,Klein HH

    更新日期:2000-09-01 00:00:00

  • Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin.

    abstract::Epidemiologic data suggest that having a parent with Type 2 (non-insulin-dependent) diabetes mellitus increases the risk for Type 1 (insulin-dependent) diabetes in siblings of a Type 1 diabetes proband. This increase in risk is consistent with a shared genetic susceptibility between Type 1 diabetes and Type 2 diabetes...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00405008

    authors: Rich SS,Panter SS,Goetz FC,Hedlund B,Barbosa J

    更新日期:1991-05-01 00:00:00